Follicular lymphoma -- typically a slow-growing ... showed that 29% of patients in a watch-and-wait group still didn't need therapy at 10 years, and no significant difference in 10-year OS rates ...

Specific host factors, such as immune cell activity, sex hormones and microbiota composition, influence the ability of Staphylococcus aureus bacteria to colonize the gut of mice.

CAR T-cell therapy shows promising results in treating ... (38 with diffuse large B-cell lymphoma (DLBCL) and three with follicular lymphoma (FL)) received an infusion of tisa-cel.

"Follicular lymphoma is very heterogenous, and ctDNA may capture the more prominent mutations that are associated with prognosis." "But ... for now, we really don't have any tool at the time of ...

Researchers sought to assess the access to CAR-T therapy for patients within community-based and transplant cell therapy networks.

Watchful waiting—also known as active surveillance—is a common approach for asymptomatic, advanced stage follicular lymphoma, ...

It’s spring, a time for new beginnings following a cancer diagnosis; however, I have an ongoing issue that I can’t dismiss.

Follicular lymphoma is the ... earlier approvals for diffuse large B-cell lymphoma (DLBCL) and acute lymphoblastic leukaemia. Kymriah was the first CAR-T to reach the market in 2017, but was ...

There may be “substantial delays” between when a drug is granted accelerated approval for a cancer indication, when negative trial results are released, and when the accelerated approval of the drug ...